Incidence of noninfectious conditions in perinatally HIV-infected children and adolescents in the HAART era. (Q37315190)

19 August 2017

Incidence of noninfectious conditions in perinatally HIV-infected children and adolescents in the HAART era. (English)

1 reference

19 August 2017

0 references

1 reference

3

Philimon Gona

0 references

George Seage

6

object named as

George R Seage

1 reference

19 August 2017

1

Sharon A Nachman

1 reference

19 August 2017

8

Paige L Williams

1 reference

19 August 2017

Miriam Chernoff

2

1 reference

19 August 2017

Russell B Van Dyke

4

1 reference

19 August 2017

Wayne M Dankner

5

1 reference

19 August 2017

James Oleske

7

1 reference

19 August 2017

PACTG 219C Team

9

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 February 2009

1 reference

19 August 2017

1 reference

19 August 2017

163

1 reference

19 August 2017

2

1 reference

19 August 2017

164-171

1 reference

Cardiovascular risks of antiretroviral therapies

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2730663

Infection and musculoskeletal conditions: Rheumatologic complications of HIV infection.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2730663

Incidence of opportunistic and other infections in HIV-infected children in the HAART era.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2730663

Cardiovascular toxicity with highly active antiretroviral therapy: review of clinical studies

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2730663

Opportunistic infections: an update

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2730663

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2730663

Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compart

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2730663

Predictors of adherence to antiretroviral medications in children and adolescents with HIV infection

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2730663

Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2730663

The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2730663

Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, San Francisco, 1994-1998.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2730663

Correlates of opportunistic infections in children infected with the human immunodeficiency virus managed before highly active antiretroviral therapy

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2730663

Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2730663

Reproductive health of adolescent girls perinatally infected with HIV

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2730663

Antiretroviral Treatment in Pediatric HIV Infection in the United States From Clinical Trials to Clinical Practice

20 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2730663

Effect of Combination Therapy Including Protease Inhibitors on Mortality among Children and Adolescents Infected with HIV-1

3 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2730663

Determinants of Low-Risk and High-Risk Cervical Human Papillomavirus Infections in Montreal University Students

3 December 2018

1 reference

12 December 2020

Patterns of opportunistic infections in patients with HIV infection

1 reference

12 December 2020

Toxicities of antiretroviral therapy in children

1 reference

12 December 2020

Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study

1 reference

12 December 2020

10.1001/ARCHPEDI.163.2.164

Identifiers

DOI

1 reference

19 August 2017

1 reference

19 August 2017

1 reference